The largest holder of BioNTech stock is Fidelity Management & Research Co. LLC, with 7.6 million shares (3.15% of the company), worth about $769.00 million as of September 25, 2026. The 10 largest holders together own 10.5%.
In Q2 2026, 320 institutional holdings reports listed 47.4 million shares worth $4.82 billion, down 0.2% in shares from Q1 2026.
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026).

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Fidelity Management & Research Co. LLC | 7.6 million | 3.15% | $769.0M |
| PRIMECAP Management Co. | 3.8 million | 1.57% | $383.0M |
| Dodge & Cox | 3.7 million | 1.53% | $374.0M |
| Flossbach von Storch SE | 2.2 million | 0.93% | $226.0M |
| T. Rowe Price Investment Management, Inc. | 2.1 million | 0.86% | $210.0M |
| Temasek Holdings Pte Ltd. | 1.5 million | 0.63% | $153.0M |
| BNP Paribas Arbitrage SA | 1.3 million | 0.55% | $134.0M |
| BlackRock Advisors LLC | 1.1 million | 0.46% | $113.0M |
| Logos Global Management LP | 1.0 million | 0.42% | $103.0M |
| Gsk PLC | 889,824 | 0.37% | $90.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 320 | 47.4 million | $4.8B |
| Q1 2026 | 307 | 47.5 million | $4.2B |
| Q4 2025 | 330 | 51.1 million | $4.9B |
| Q3 2025 | 293 | 50.5 million | $5.0B |
| Q2 2025 | 295 | 53.8 million | $5.7B |
| Q1 2025 | 316 | 51.8 million | $4.7B |
| Q4 2024 | 347 | 50.9 million | $5.8B |
| Q3 2024 | 350 | 44.3 million | $5.3B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Fidelity Management & Research Co. LLC, with 3.15% of the company (as of September 25, 2026). Next: PRIMECAP Management Co. (1.57%) and Dodge & Cox (1.53%).
320 institutional holdings reports listed BioNTech shares in Q2 2026, 47.4 million shares in all worth $4.82 billion.